基本信息
浏览量:299
职业迁徙
个人简介
Dr. Lerman is nationally recognized for her cancer prevention research that bridges the fields of neuroscience, pharmacology, genetics, and behavioral science. She produced the first empirical data on the outcomes of genetic testing for cancer susceptibility and was among the first to publish evidence for the genetic basis of cancer risk behaviors. Her pioneering work identifying genetic influences on tobacco use culminated in the first prospective stratified pharmacogenomic trial in the field of tobacco dependence, which has had a considerable impact on the application of precision medicine for tobacco dependence treatment.
Supported by her National Cancer Institute (NCI) Outstanding Investigator Award (R35), Dr. Lerman now also leads a highly novel research program that harnesses advances in cognitive neuroscience to promote cancer risk behavior change. She has published over 380 peer reviewed publications, which have been cited over >20,000 times. Dr. Lerman is an elected member of the National Academy of Medicine and President-Elect of the American Association of Cancer Institutes (AACI). She has served as a member of the NCI Board of Scientific Advisors, the National Human Genome Research Institute Advisory Council, and the National Institute on Drug Abuse Advisory Council. Currently, she serves as a standing member of the National Cancer Institute Subcommittee A for Cancer Center Reviews.
Supported by her National Cancer Institute (NCI) Outstanding Investigator Award (R35), Dr. Lerman now also leads a highly novel research program that harnesses advances in cognitive neuroscience to promote cancer risk behavior change. She has published over 380 peer reviewed publications, which have been cited over >20,000 times. Dr. Lerman is an elected member of the National Academy of Medicine and President-Elect of the American Association of Cancer Institutes (AACI). She has served as a member of the NCI Board of Scientific Advisors, the National Human Genome Research Institute Advisory Council, and the National Institute on Drug Abuse Advisory Council. Currently, she serves as a standing member of the National Cancer Institute Subcommittee A for Cancer Center Reviews.
研究兴趣
论文共 541 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CLINICAL PHARMACOLOGY & THERAPEUTICS (2024)
HUMAN MOLECULAR GENETICSno. 2 (2024): 198-210
The Journal of Neuroscienceno. 9 (2023): 1600-1613
引用4浏览0引用
4
0
PHARMACOGENETICS AND GENOMICSno. 8 (2023): 187-188
引用0浏览0引用
0
0
Timothy J. Wanger, Fernando B. de Moura,Rebecca Ashare,James Loughead,Scott Lukas,Caryn Lerman,Amy C. Janes
ADDICTION BIOLOGYno. 12 (2023): e13338-e13338
引用0浏览0WOS引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn